TY - JOUR
T1 - 'HTA for Crisis'
T2 - Sharing experiences during the 7th EBHC Symposium
AU - Wladysiuk, Magdalena
AU - Tabor, Anna
AU - Godman, Brian
N1 - Funding Information:
Session 4 discussed approaches to healthcare provision within countries undergoing economic problems. Kristina Garuoline (National Health Insurance Fund under the Ministry of Health of the Republic of Lithuania, Vilnius, Lithuania) described decision-making process for funding drugs in Lithuania. Scoring systems are being developed by the Ministry of Health’s Commission for Modification of the list of diseases and reimbursement with reimbursement granted on the basis of scoring. Reforms have also been instigated regarding the pricing of generics and originators to free resources to start reimbursing new pharmaceuticals [1]. Jurij Furst (Ministry of Health of the Republic of Slovenia, The Health Insurance Institute of Slovenia, Ljubljana, Slovenia) stated that the crisis presented opportunities to improve the effectiveness of pharmaceutical policy. Economic criteria have become much stricter when reviewing the value of new drugs. Explicitly defined incremental cost–effectiveness ratio threshold is one option. Recently, reference pricing for therapeutic groups of drugs has been introduced in Slovenia to further conserve resources with compulsory generic substitution planned [2]. Alongside this, quality indicators are also being developed especially where there is polypharmacy [3]. Only motivated physicians and pharmacists with sophisticated technical support will prescribe rationally, which is the ultimate goal of the policy. Jacek Gralinski (Children’s Memorial Health Institute, Warsaw, Poland) spoke on rare diseases. There is concern about the costs of drugs for orphan diseases, which has led researchers to question current definitions and practices [4].
PY - 2013/2
Y1 - 2013/2
N2 - 'HTA for Crisis'-7th Evidence-Based Health Care Symposium organized by the Central and Eastern European Society for Technology Assessment in Healthcare Krakow, Poland, 8-9 October 2012 The Central and Eastern European Society of Technology Assessment in Health Care was founded in Krakow, Poland in 2003. On October 8th and 9th, the 7th symposium took place titled 'HTA for Crisis'. This meeting was attended by over 250 decision makers, evidence-based specialists, healthcare managers, commercial company personnel and experts. The symposium was principally divided into four main themes: insurance in times of crisis; importance of pricing of health services in times of crisis; managing welfare benefits in times of crisis and Health Technology Assessment in crisis-laden countries. The symposium finished by debating potential ways forward for healthcare systems in times of crisis.
AB - 'HTA for Crisis'-7th Evidence-Based Health Care Symposium organized by the Central and Eastern European Society for Technology Assessment in Healthcare Krakow, Poland, 8-9 October 2012 The Central and Eastern European Society of Technology Assessment in Health Care was founded in Krakow, Poland in 2003. On October 8th and 9th, the 7th symposium took place titled 'HTA for Crisis'. This meeting was attended by over 250 decision makers, evidence-based specialists, healthcare managers, commercial company personnel and experts. The symposium was principally divided into four main themes: insurance in times of crisis; importance of pricing of health services in times of crisis; managing welfare benefits in times of crisis and Health Technology Assessment in crisis-laden countries. The symposium finished by debating potential ways forward for healthcare systems in times of crisis.
UR - http://www.scopus.com/inward/record.url?scp=84873923021&partnerID=8YFLogxK
U2 - 10.1586/erp.12.92
DO - 10.1586/erp.12.92
M3 - Article
C2 - 23402445
AN - SCOPUS:84873923021
SN - 1473-7167
VL - 13
SP - 47
EP - 49
JO - Expert Review of Pharmacoeconomics and Outcomes Research
JF - Expert Review of Pharmacoeconomics and Outcomes Research
IS - 1
ER -